Is Grace Risk Score the Holy Grail in Risk Stratification or Can We Improve it Even Further with Additional Biomarkers?
| Autor principal: | |
|---|---|
| Formato: | other |
| Idioma: | eng |
| Publicado em: |
2021
|
| Assuntos: | |
| Texto completo: | http://hdl.handle.net/10400.17/3777 |
| País: | Portugal |
| Oai: | oai:repositorio.chlc.min-saude.pt:10400.17/3777 |